We are excited to announce our CEO, Lucas Nivon, will be speaking at BIO Asia-Taiwan! He'll be discussing AI in Biologics Discovery as part of the “AI-Driven Innovation in Drug Discovery” track. bit.ly/4nt5T7H #BIOAsiaTaiwan #AI #DrugDiscovery

Cyrus's CEO, Lucas Nivon, is the keynote speaker for Nucleate Seattle’s Activator Demo Day! Join us to hear him speak about Life Sciences Commercialization on May 14th at the Allen Institute. #Seattle #Biotech #Innovation lu.ma/18yj2jg3?tk=...

Nucleate Seattle: 2025 Demo Day · Luma

Please join Nucleate Seattle in celebrating our 2025 Activator cohort at our Demo Day! We invite all biotech and bio-entrepreneurial enthusiasts of all stages…

lu.ma

Our CSO, Erik Procko, is speaking at PEGS Boston! Join him 5/13 at 5:10pm ET for his talk: A Library-Based Approach for Mapping and Engineering HLA-II Epitope Landscapes. #PEGSBoston #AI #ML #Biotech #Immunogenicity #CyrusBio tinyurl.com/mr2v3hxa

OpenFold announces new data sharing agreement that allows lead AI scientist, Mohammed AlQuraishi, to use proprietary data to train State of the Art generative AI models. Possible because Openfold is fully open source! Stay tuned for more about OpenFold3. www.statnews.com/2025/03/27/a...

AbbVie, J&J to add proprietary data to AI protein model in bid to accelerate drug discovery

Imagine standing on a vast, dark plain. Without light, you cannot see dips and rolls in the grass or make out hills and valleys. Even if there’s a city

statnews.com

Our CEO, Lucas Nivon, will be presenting at BIOVIA Connect on April 2, 2025! Join us to hear Lucas share about the development of OpenFold3. Learn more about the event here: lnkd.in/gw4MWZsT #BIOVIAConnect #MolecularModeling #AI #OpenFold3

Today is Autoimmune Hemolytic Anemia Awareness Day. Cyrus Bio works to bring new and effective therapies to AIHA patients. We are just embarking on this journey but look forward to marking this day with those affected by AIHA for many years to come. #RareDiseases #Autoimmune #HemolyticAnemia